BlackRock Amends Utah Medical Products Stake, Remains Passive
Ticker: UTMD · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investing, amendment, medical-devices
TL;DR
**BlackRock still owns Utah Medical Products stock, but it's a passive stake.**
AI Summary
BlackRock, Inc. filed an amended Schedule 13G/A on January 29, 2024, disclosing its ownership of Utah Medical Products Inc. common stock as of December 31, 2023. This filing, Amendment No. 4, indicates BlackRock's continued passive investment in the medical device company. For investors, this means a major institutional investor maintains a position, which can signal confidence, but the passive nature suggests no immediate activist intentions.
Why It Matters
This filing shows BlackRock, a major institutional investor, continues to hold shares in Utah Medical Products Inc., which can be a positive signal for current and prospective shareholders.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any significant new risks or opportunities.
Analyst Insight
Investors should note BlackRock's continued passive stake, but understand this filing doesn't signal any new strategic moves or significant changes in the company's outlook. It's a routine disclosure of an existing position.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Utah Medical Products Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will maintain a passive investment in Utah Medical Products Inc. for the foreseeable future. (BlackRock, Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934. Specifically, it is Amendment No. 4.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., a major institutional investment manager based in New York, NY.
What company's securities are being reported on?
The securities being reported on are the Common Stock of Utah Medical Products Inc., a company based in Midvale, UT, with CUSIP Number 917488108.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding UTAH MEDICAL PRODUCTS INC (UTMD).